Mission statement · Company scope
“Our mission is to develop and commercialize technologies to treat diseases of the heart, with an initial focus on the Holly Graft System for use in CABG.”
In use2004 – now1 sighting
First seenDec 2004Added
Last seenDec 2004Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Innovation (primary) · Product offering
- Leads with
- Invention
- Best for
- Climate & health
- Formula
- We’re building [new thing] so [result]
- Tone
- Warm · Technical
- Length
- 27 words · reading grade 13.7
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_e323ac6b50007964
- Classification confidence
- 0.59
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2004-12-08 · sec_sentence · 424B4 · accession 0000950134-04-018803
View filing ↗0 to compareCompare